The transaction was structured as a non-c On Target for Mid-2025 New Drug Application (NDA) Submission of lead ADHD asset CTx-1301KANSAS CITY, Kan., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc.

Jan. 28, 2025 — A new one-minute video game is able to accurately and efficiently identify children with autism from those who have ADHD or are ... Adults Diagnosed With ADHD May Have Reduced ...

The specific contribution of the cerebellum to typical development may therefore involve the optimization of the structure and function of cerebro-cerebellar circuits underlying skill acquisition in ...

The symptoms and impairments associated with ADHD often cause significant mental suffering in affected individuals. ADHD has been associated with abnormal neuronal activity in various neuronal ...

The rating was based on a Discounted Cash Flow (DCF) analysis and promising Phase 3 data of Cingulate's CTx-1301, a treatment for Attention Deficit Hyperactivity Disorder (ADHD). The United States ...

Psychedelic compounds produce intense subjective experiences and have shown promise in the treatment of posttraumatic stress disorder (PTSD) and treatment-resistant depression, amongst other ...

Anger and irritability aren’t part of the criteria used to diagnose ADHD, but clinicians and researchers have identified them as common experiences among children and adults with the condition.

These include parts of the prefrontal cortex (important for decision-making and cognitive control), the hippocampus, the anterior cingulate cortex ... brain’s reward circuit in ways that ...

ccf.org Objective Posterior cingulate epilepsy (PCE) is misleading because the seizure onset is located in an anatomically deep and semiologically silent area. This type of epilepsy is rare and has ...